Literature DB >> 7974309

The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis.

F E Perry, J R Catterall.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7974309      PMCID: PMC475226          DOI: 10.1136/thx.49.10.946

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  73 in total

1.  Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.

Authors:  M R Szewczuk; R J Campbell; L K Jung
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

2.  From the National Institutes of Health.

Authors:  B Healy
Journal:  JAMA       Date:  1993-04-07       Impact factor: 56.272

3.  Cytokine measurements in septic shock.

Authors:  C A Dinarello; J G Cannon
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

4.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen.

Authors:  M Porro; P Costantino; S Viti; F Vannozzi; A Naggi; G Torri
Journal:  Mol Immunol       Date:  1985-08       Impact factor: 4.407

6.  Purification and properties of Streptococcus pneumoniae neuraminidase.

Authors:  K L Scanlon; W F Diven; R H Glew
Journal:  Enzyme       Date:  1989

7.  Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Authors:  R Schneerson; J B Robbins; J C Parke; C Bell; J J Schlesselman; A Sutton; Z Wang; G Schiffman; A Karpas; J Shiloach
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae.

Authors:  F E Perry; C J Elson; T J Mitchell; P W Andrew; J R Catterall
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

Review 9.  Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

10.  Immunization of mice with Salmonella typhimurium C5 aroA expressing a genetically toxoided derivative of the pneumococcal toxin pneumolysin.

Authors:  J C Paton; J K Morona; S Harrer; D Hansman; R Morona
Journal:  Microb Pathog       Date:  1993-02       Impact factor: 3.738

View more
  1 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.